CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
the Press Release attached as Exhibit 99.1 to this report. The
Press Release provides details related to the Companys financial
results and earnings for the fiscal year ended December 31, 2016
and the three months ended December 31, 2016.
including Exhibit 99.1 attached hereto, shall not be deemed filed
for purposes of Section18 of the Securities Exchange Act of 1934,
as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated
by reference into any other filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such a filing.
announced that after a lengthy strategic review process, the
Board was unable to execute a sale of the business. The Board, in
consultation with the Companys financial advisor, Boxwood
Partners, LLC, made the decision to discontinue sale talks with
bidders after having been engaged in negotiations for a lengthy
period of time.The Company continues to have high level
discussions regarding mergers and acquiring other related
businesses that may have high cash synergies without increased
complexity.A copy of the Press Release is furnished as Exhibit
99.1 to this Current Report on Form 8-K and incorporated by
reference in this Item7.01.
including Exhibit 99.1 attached hereto, shall not be deemed filed
for purposes of Section18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference into
any other filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as expressly set forth by specific
reference in such a filing.
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated March 28, 2017
|
About CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI)
Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI’s subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord’s operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage. CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Recent Trading Information
CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) closed its last trading session 00.00000 at 0.00260 with shares trading hands.
